Acuity Brands Lighting, Inc. v. Ultravision Technologies, LLC

CourtDistrict Court, D. Delaware
DecidedJuly 28, 2021
Docket1:19-cv-02207
StatusUnknown

This text of Acuity Brands Lighting, Inc. v. Ultravision Technologies, LLC (Acuity Brands Lighting, Inc. v. Ultravision Technologies, LLC) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Acuity Brands Lighting, Inc. v. Ultravision Technologies, LLC, (D. Del. 2021).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

ACUITY BRANDS LIGHTING, INC., ) ) Plaintiff, ) ) v. ) C.A. No. 19-2207 (MN) ) ULTRAVISION TECHNOLOGIES, LLC, ) ) Defendant. ) MEMORANDUM ORDER At Wilmington this 28th day of July 2021: IT IS HEREBY ORDERED that the claim terms of U.S. Patents Nos. 8,870,410 (“the ’410 Patent”), 8,870,413 (“the ’413 Patent”), 9,734,738 (“the ’738 Patent”), 9,947,248 (“the ’248 Patent”), and 10,223,946 (“the ’946 Patent”) (collectively, “the Patents-in-Suit”) with agreed-upon constructions (see D.I. 92-1), are construed as follows: 1. “acrylic material” / “acrylic material substrate” means “material containing primarily acrylates” / “substrate containing primarily acrylates” (’410 Patent, cl. 15; ’413 Patent, cl. 4, 10, 12); 2. The preambles “An optics panel for use in a light emitting diode (LED) lighting assembly comprising” / “An optics panel for use in a light emitting diode (LED) lighting assembly for illuminating a billboard that has a display surface extending between outer edges of the billboard, the optics panel comprising” are limiting (’410 Patent, cl. 1, 10, 15; ’413 Patent, cl. 1, 5, 11); 3. “substantially transparent” means “transparent” (’410 Patent, cl. 1; ’413 Patent, cl. 5, 11); 4. “predetermined bounded area” means “area determined by the dimensions of the [display surface]” (’410 Patent, cl. 1); 5. “substantially the entire display surface” shall have its plain and ordinary meaning of “the entire display surface” (’410 Patent, cl. 1, 15); 6. “optics panel” shall have its plain and ordinary meaning, and the optics panels of independent claims 1 and 15 of the ’410 Patent and claims 1, 5, and 11 of the ’413 Patent comprise the respective elements of those claims (’410 Patent, cl. 1, 10, 11, 15; ’413 Patent, cl. 1, 5, 11); and 7. “wherein each lens is disposed over only one associated LED” / “each optical element disposed over only one associated LED” / “each optical element is disposed over only one associated LED” / “each optical element overlies only one associated LED” / “each optical element overlies only one associated LED” / “each convex optical element overlying an associated one of the LEDs” / “each optical element . . . overlies a respective one of the LEDs” shall have their plain and ordinary meaning of “each [lens/optical element/convex optical element] is disposed over only one LED” (’410 Patent, cl. 10; ’413 Patent, cl. 1, 5, 11; ’738 Patent, cl. 1, 10; ’248 Patent, cl. 1, 10; ’946 Patent, cl. 29). Further, as announced at the hearing on July 21, 2021, IT IS HEREBY ORDERED that the following disputed claim terms of the Patents-in-Suit are construed as follows: 1. “substantially uniform / substantially equal level of illumination / a uniformity . . . remains substantially unchanged / the uniformity of light . . . remains substantially the same / a uniformity of light . . . remains substantially the same / a uniformity of light . . . remains substantially unchanged” mean “a level of illumination that does not create unnoticeable unevenness in the overall illumination (’410 Patent, cl. 1, 10, 15; ’248 Patent, cl. 3; ’738 Patent, cl. 11, 13; ’946 Patent, cl. 12); 2. “lens element” means “a geometrically distinct part of a lens” (’410 Patent cl. 1, 16, 22; ’413 Patent cl. 3, 7, 13); 3. “convex optical element” means “a lens that curves or bulges outward” (’946 Patent cl. 1, 21, 29); 4. “display surface” means “sign surface” (’410 Patent, cl. 1, 7, 10, 12, 14, 15, 19, 20, 21, 25, 26; ’413 Patent, cl. 1, 2, 4, 5, 6, 10, 11, 12, 16, 17); 5. “area” / “substantially rectangular area” mean “area of a sign” / “substantially rectangular area of a sign” (’946 Patent, cl. 1, 21, 24, 29; ’248 Patent, cl. 1, 10, 11, 12); 6. “configured to” / “configured so” means “designed to” / “designed so” (’410 Patent, claims 1, 10, 15; ’413 Patent, claims 1, 5, 11; ’738 Patent, claims 1, 10, 11, 12, 14; ’248 Patent, claims 1, 3, 10, 11; ’946 Patent, claims 1, 12, 21, 24, 29); and 7. “[average illumination to minimum illumination uniformity ratio] is 3:1 / [a ratio of the average illumination from that LED across the entire display surface to the minimum illumination from that LED at any point on the display surface] is 3:1 / [a ratio of the average illumination from each of the LEDs across the entire display surface to the minimum illumination at any point on the display surface from each of the LEDs] is 3:1 / [a ratio of the average illumination from that LED across the entire display surface to the minimum illumination from that LED at any point on the display surface] is 3:1 / [ratio of the average illumination from each LED across the entire display surface to the minimum illumination from that LED at any point on the display surface] [[to]] is 3:1” mean “has a ratio of 3:1” (’410 Patent, cl. 5, 14, 20; ’413 Patent, cl. 1, 5, 11). The parties briefed the issues, (see D.I. 93), and submitted a Joint Claim Construction Chart containing intrinsic evidence, (see D.I. 92-1). The Court carefully reviewed all submissions in connection with the parties’ contentions regarding the disputed claim terms, heard oral argument, (see D.I. 100), and applied the following legal standards in reaching its decision. I. LEGAL STANDARDS A. Claim Construction “[T]he ultimate question of the proper construction of the patent [is] a question of law,” although subsidiary fact-finding is sometimes necessary. Teva Pharms. USA, Inc. v. Sandoz, Inc., 135 S. Ct. 831, 837-38 (2015). “[T]he words of a claim are generally given their ordinary and customary meaning [which is] the meaning that the term would have to a person of ordinary skill in the art in question at the time of the invention, i.e., as of the effective filing date of the patent application.” Phillips v. AWH Corp., 415 F.3d 1303, 1312-13 (Fed. Cir. 2005) (en banc) (internal citations and quotation marks omitted). Although “the claims themselves provide substantial guidance as to the meaning of particular claim terms,” the context of the surrounding words of the claim also must be considered. Id. at 1314. “[T]he ordinary meaning of a claim term is its meaning to the ordinary artisan after reading the entire patent.” Id. at 1321 (internal quotation marks omitted). The patent specification “is always highly relevant to the claim construction analysis . . . [as] it is the single best guide to the meaning of a disputed term.” Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1582 (Fed. Cir. 1996). It is also possible that “the specification may reveal a special definition given to a claim term by the patentee that differs from the meaning it would

otherwise possess. In such cases, the inventor’s lexicography governs.” Phillips, 415 F.3d at 1316. “Even when the specification describes only a single embodiment, [however,] the claims of the patent will not be read restrictively unless the patentee has demonstrated a clear intention to limit the claim scope using words or expressions of manifest exclusion or restriction.” Hill-Rom Servs., Inc. v. Stryker Corp., 755 F.3d 1367, 1372 (Fed. Cir. 2014) (internal quotation marks omitted) (quoting Liebel-Flarsheim Co. v. Medrad, Inc., 358 F.3d 898, 906 (Fed. Cir. 2004)). In addition to the specification, a court “should also consider the patent’s prosecution history, if it is in evidence.” Markman v. Westview Instruments, Inc., 52 F.3d 967, 980 (Fed. Cir.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Warner-Jenkinson Co. v. Hilton Davis Chemical Co.
520 U.S. 17 (Supreme Court, 1997)
Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co.
535 U.S. 722 (Supreme Court, 2002)
Microsoft Corp. v. i4i Ltd. Partnership
131 S. Ct. 2238 (Supreme Court, 2011)
Aspex Eyewear, Inc. v. Marchon Eyewear, Inc.
672 F.3d 1335 (Federal Circuit, 2012)
Vitronics Corporation v. Conceptronic, Inc.
90 F.3d 1576 (Federal Circuit, 1996)
Ecolab, Inc. v. Envirochem, Inc.
264 F.3d 1358 (Federal Circuit, 2001)
Ntp, Inc. v. Research in Motion, Ltd.
418 F.3d 1282 (Federal Circuit, 2005)
Technology Licensing Corp. v. Videotek, Inc.
545 F.3d 1316 (Federal Circuit, 2008)
Nautilus, Inc. v. Biosig Instruments, Inc.
134 S. Ct. 2120 (Supreme Court, 2014)
Hill-Rom Services, Inc. v. Stryker Corporation
755 F.3d 1367 (Federal Circuit, 2014)
Biosig Instruments, Inc. v. Nautilus, Inc.
783 F.3d 1374 (Federal Circuit, 2015)
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.
789 F.3d 1335 (Federal Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
Acuity Brands Lighting, Inc. v. Ultravision Technologies, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/acuity-brands-lighting-inc-v-ultravision-technologies-llc-ded-2021.